NCT03341689 - Psilocybin for the Treatment of Migraine Headache | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

April 30, 2021

Study Completion Date

October 31, 2021

Conditions

Migraine Headache

Interventions

DRUG

High Dose Psilocybin

0.143 mg/kg psilocybin capsule

DRUG

Low Dose Psilocybin

0.0143 mg/kg psilocybin capsule

DRUG

Placebo

microcrystalline cellulose capsule

Trial Locations (1)

VA Connecticut Healthcare System, West Haven Campus, West Haven